MNOV
MediciNova·NASDAQ
--
--(--)
--
--(--)
4.70 / 10
Netural
Capital flow assessment yields 7.14/10, denoting robust fund flow characteristics. Strengths in no significant trends trends confront pressures from overall, block, Small, Medium, Large, and Extra-large patterns, resulting in positive liquidity outlook. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(100.0%) from 1 analyst assessments, supported by 2.26 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionD. Boral Capital
Times predicted11
Historical Win Rate18.2%
Is money flowing into or out of MNOV?
- MNOV holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.70/10 (Netural).
